Jose M. Flores, MD, MHA
Assistant Attending Surgeon
Sexual and Reproductive Medicine; Erectile Dysfunction; Low Testosterone; Ejaculation and Orgasm Disorders; Peyronie’s Disease; Male Onco-Fertility; Male Infertility
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Flores accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, University of Chile School of Medicine; MHA, University of the Andes
Surgery, University of Chile; Urology, University of Chile
Urology, University of Minnesota; Andrology, University of Illinois at Chicago; Sexual and Reproductive Medicine, MSKCC
Urology (Chile); American Board of Urology Alternative Pathway to Certification for International Medical Graduates
I am a urologic surgeon specializing in male sexual and reproductive health. At Memorial Sloan Kettering Cancer Center (MSK), I often see men with active cancer or a history of cancer. We meet before and after treatment to address its effects on sexual function and fertility and, when relevant, to discuss available medical and/or surgical interventions that can alleviate problems related to sex and fertility. I also provide sexual and reproductive healthcare to men who have never been diagnosed with cancer.
In collaboration with MSK’s sexual and reproductive medicine team, I manage a variety of conditions, such as erectile dysfunction, ejaculation and orgasm disorders, low testosterone, male infertility, varicocele, and Peyronie’s disease. The surgeries that I perform include microsurgical testicular sperm extraction pre- and post-cancer treatment, penile prosthesis, microsurgical varicocelectomies, hydrocelectomies, penile plication, circumcisions, vasectomies, and vasectomy reversals. I also have expertise in penile doppler ultrasound as a diagnostic tool for evaluating erectile dysfunction and intralesional injection therapy for men with Peyronie’s disease.
My goal is to improve my patients’ health and quality of life by using the most effective treatments available, tailored to their specific needs and priorities. I strive to help patients make the best decisions about their care by clearly presenting the relevant medical information, discussing treatment options and expectations, and addressing all their concerns with compassion.
I completed three years of clinical fellowship training in urology, spending one year at the University of Illinois at Chicago and two years at MSK. Additionally, I have nearly a decade of clinical experience as an attending urologist in my native country of Chile. My clinical training and experience dovetails with research; I have been involved in academic research throughout my career and served as a research fellow for two years in the Department of Urology at the University of Minnesota. The clinical research I am currently conducting focuses on:
- Defining comorbidity profile factors associated with erectile function recovery after radical pelvic surgery,
- assessing the safety of testosterone therapy in men with prostate cancer,
- identifying factors associated with penile curvature improvement in men with Peyronie’s disease,
- the psychological impact of Peyronie’s disease,
- evaluating factors associated with sexual dysfunction and low testosterone in survivors of testicular cancer,
- fertility preservation in men with testicular cancer, and
- predictors of fertility preservation in men after oncological treatment.
When I am not working, I enjoy spending time with my wife and children, exploring New York, and traveling.
Awards and Honors
- Abstract (“Analyzing the impact of testosterone on bone density loss”) selected for the American Urological Association Annual Meeting Press Program (2022)
- William P Conners III Best Abstract in Fertility & Andrology Prize, awarded for ”Testosterone challenge in men post-radical prostatectomy with profoundly low testosterone,” the Sexual Medicine Society of North America (2021)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Marconi M, Palma C, Moreno S, Flores JM, Urreojola E. Trends in treatments for erectile dysfunction in Chile between 2010 and 2020 with special focus on penile prostheses. Archivo Italiano di Urologia e Andrologia. 2022; 94,1.
Flores JM, Bernie HL, Miranda E, Nascimento B, Schofield E, Tin A, Benfante N, Carlsson S, Mulhall JP. The relationship between PSA and total testosterone levels in men with prostate cancer. J Sex Med. 2022;19(3), 471-478. PMCID: 35135736.
Flores JM, Salter CA, Nascimento B, Terrier JE, Taniguchi H, Bernie H, Miranda E, Jenkins L, Schofield E, Mulhall JP. The prevalence and predictors of penile pain in men with Peyronie’s disease. Sexual Medicine, Open Access journal. 2021;9 (4):100398. PMCID: 34246855.
Punjani N, Nascimento B, Salter C, Flores J, Miranda E, Terrier J, Taniguchi H, Jenkins L, Mulhall JP. Predictors of pursuing intralesional Xiaflex in Peyronie’s disease patients. J Sex Med. 2021 Jul;18(7):1258-1264. PMCID: 34226137.
Punjani N, Bernie H, Salter C, Flores J, Benfante N, Mulhall JP. The utilization and impact of aromatase inhibitor therapy in men with elevated estradiol levels on testosterone therapy. Sexual Medicine, Open Access journal. 2021;9 (4):100378. PMCID: 34090245.
Morgantini LA, Naha U, Wang H, Francavilla S, Acar O, Flores JM, Crivellaro S, Moreira D, Abern M, Eklund M, Vigneswaran HT, Weine SM. Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey. PLoS One. 2020;15(9). PMCID: 32881887.
Valdevenito JP, Flores J, Rojas RG, Manriquez V, Arribillaga L, Benito J. Voiding symptoms obtained by open versus directed anamnesis as predictors of voiding dysfunction in women. Int Braz J Urology. 2019;30:45. PMCID: 31184452.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jose M. Flores discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.